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Executive function (EF) has been defined as a multifaceted construct that involves a
variety of high-level cognitive abilities such as planning, workingmemory, mental flexibility,
and inhibition. Being able to identify deficits in EF is important for the diagnosis and
monitoring of several neurodegenerative disorders, and thus their assessment is a topic
of much debate. In particular, there has been a growing interest in the development of
neuropsychological screening tools that can potentially provide a reliable quick measure
of EF. In this review, we critically discuss the four screening tools of EF currently
available in the literature: Executive Interview-25 (EXIT 25), Frontal Assessment Battery
(FAB), INECO Frontal Screening (IFS), and FRONTIER Executive Screen (FES). We first
describe their features, and then evaluate their psychometric properties, the existing
evidence on their neural correlates, and the empirical work that has been conducted
in clinical populations. We conclude that the four screening tools generally present
appropriate psychometric properties, and are sensitive to impairments in EF in several
neurodegenerative conditions. However, more research will be needed mostly with
respect to normative data and neural correlates, and to determine the extent to which
these tools add specific information to the one provided by global cognition screening
tests. More research directly comparing the available tools with each other will also be
important to establish in which conditions each of them can be most useful.
Keywords: aging, cognitive impairment, executive functions, neuropsychological assessment, neurodegenerative
disorders, neuropsychological screening, psychometric properties, review
INTRODUCTION
Aging is typically associated with a subtle decline in cognitive functioning, seen even in healthy
individuals (Wild-Wall et al., 2011; Pertl et al., 2017). Crucially, though, aging is also a risk
factor for neurodegenerative dementias, such as Alzheimer’s and Parkinson’s Diseases (Horton
and Wedding, 2008). Cognitive screening tests are important to diagnose these conditions and
to assess their evolution. Since they provide practical and cost-effective evaluations, using them
can be extremely valuable for healthcare systems, that are often under pressure to reduce costs
and operate under time constraints (Larner, 2013a). Guidelines for screening tests have been
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presented by the Committee on Research of the American
Neuropsychiatric Association (Malloy et al., 1997): they
should be brief (<15min), easy to administer, and present
appropriate sensitivity, specificity, test-retest, and inter-rater
validities. In primary care, clinicians typically rely on global
cognition screening tools such as the Addenbrooke’s Cognitive
Examination (ACE; Mathuranath et al., 2000), Mini-Mental
State Examination (MMSE; Folstein et al., 1975), or Montreal
Cognitive Assessment (MoCA; Nasreddine et al., 2005).
However, more specific screening instruments are also important
(Cullen et al., 2007; Larner, 2013a), notably in diseases where
deficits in specific cognitive domains are expected. Dysexecutive
impairments, in particular, are an early feature of vascular (e.g.,
McGuiness et al., 2010) and neurodegenerative dementias (e.g.,
Baudic et al., 2006; Huey et al., 2009; Tartaglia et al., 2012).
Screening tools for executive functions (EF) are thus central for
evidence-based approaches in these conditions. In this review,
we discuss the four currently available screening instruments for
EF: Executive Interview (EXIT 25; Royall et al., 1992), Frontal
Assessment Battery (FAB; Dubois et al., 2000), INECO Frontal
Screening (IFS; Torralva et al., 2009), and FRONTIER Executive
Screen (FES; Leslie et al., 2015).
EXECUTIVE FUNCTIONS: DEFINITION AND
NEUROANATOMICAL SUBSTRATES
EF is an umbrella term for higher-order cognitive processes
that coordinate cognitive, emotional, and motor activity during
the execution of new and complex tasks (Jurado and Rosselli,
2007; Goldstein et al., 2014). Although, their pivotal role in
cognition is established, a consensual definition is lacking
(Goldstein et al., 2014). A theoretical distinction has been
made between metacognitive and emotional EF. Metacognitive
(Ardila, 2008; Funkiewiez et al., 2012; Otero and Barker, 2014)
or cool EF (Miyake et al., 2000; Zelazo and Muller, 2002)
include goal-directed, future-oriented skills such as planning,
inhibition, flexibility, set-shifting, and workingmemory, typically
assessed in relatively decontextualized, non-emotional testing
conditions. Emotional (Ardila, 2008) or hot (Zelazo and Muller,
2002) EF, in turn, operate in contexts that involve emotion,
motivation, or reward-based decision making. However, this
distinction might not be straightforward and it has been
suggested thatmetacognitive and emotional EF are closely related
and interdependent (Panksepp, 2003; Peterson andWelsh, 2014).
According to Panksepp (1998, 2003), they tend to go together
in the most of human experiences, with affective/emotional
processes providing intrinsic value for the cognitive and
behavioral systems (see also Pessoa, 2009).
Neuroimaging studies with healthy adults (e.g., Collette et al.,
2006; Burzynska et al., 2012) and brain-damaged patients (e.g.,
Robinson et al., 2014) indicate that EF are supported by
distributed networks including frontal and posterior (mainly
parietal) cortical and subcortical regions. For instance, studies
using structural techniques found positive correlations between
prefrontal cortex (PFC) volume and performance on tasks
of EF such as the Wisconsin Card Sorting Test (WCST;
Gunning-Dixon and Raz, 2003; Burzynska et al., 2012). Evidence
from functional studies (fMRI) implicates the dorsolateral PFC
(dlPFC) and anterior cingulate areas in the performance of
metacognitive tasks such as the Tower of Hanoi (Unterrainer
et al., 2004), digit span (Yoon et al., 2007) and WCST
(Wilmsmeier et al., 2010). On the other hand, fMRI studies
with patients with frontotemporal degeneration implicate the
ventromedial PFC in the mechanisms of emotional/social
decision (Grossman et al., 2010; for a review of the PFC
involvement in social EF, see Bicks et al., 2015).
Deficits in EF are a common symptom of traumatic
(Caeyenberghs et al., 2014), vascular (McGuiness et al.,
2010), neuropsychiatric (Reichenberg et al., 2009; Fiorentino
et al., 2013; Baez et al., 2014; Caixeta et al., 2017), and
neurodegenerative conditions. Concerning neurodegenerative
conditions, executive dysfunction is a core symptom of
behavioral-variant frontotemporal dementia (bvFTD; Hodges
and Miller, 2001; Slachevsky et al., 2004; Fiorentino et al., 2013),
and it is also frequent in Parkinson’s (Lima et al., 2008; Dirnberger
and Jahanshahi, 2013) and Huntington’s diseases (You et al.,
2014). Metacognitive EF, namely planning, working memory and
fluency, seem to be the most affected ones in Parkinson’s and
Huntington’s diseases (Elliott, 2006; Leh et al., 2010; You et al.,
2014). On the other hand, bvFTD causes both metacognitive
(Huey et al., 2009) and motivational/emotional impairments
(Eslinger et al., 2012). Early stage AD patients also show executive
dysfunction (e.g., Amiéva et al., 2004), possibly before global
cognition deficits are detectable using screening measures such
as MMSE (Sgaramella et al., 2001; Stokholm et al., 2006; Clark
et al., 2012). Importantly, in these patients, the magnitude of EF
dysfunction predicts worse performance in daily living activities,
greater need of care, and higher frequency of neuropsychiatric
symptoms (Tekin et al., 2001; Swanberg et al., 2004; Stokholm
et al., 2006).
Efforts have been made to develop tools to assess executive
dysfunction. Although, detailed tests and comprehensive
batteries are available (e.g., Behavioral Assessment of
Dysexecutive Syndrome, Wilson et al., 1996), the interest
in screening tools is relatively more recent. For example, they are
not yet discussed in widely used neuropsychological assessment
handbooks (e.g., Strauss et al., 2006; Lezak et al., 2012). As
compared to comprehensive batteries, screening tools can
provide an easier, reliable, and quicker measure of EF, useful in
initial assessments, or when the available time and resources are
limited.
SCREENING TOOLS OF EXECUTIVE
FUNCTIONS
Four executive screening tools have been devised so far: EXIT 25,
FAB, IFS, and FES (see Table 1 for details).
EXIT25 (Royall et al., 1992) was the first screening tool
designed to assess EF, including working memory, verbal and
visual fluency, inhibitory control, motor programming, and
imitation behavior. It consists of 25 items and takes around
15min to administer. The scores range from 0 to 50, with
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higher values indicating worse performance. The validation
study compared EXIT 25 scores across elderly groups with
different levels of functional dependency. Contrary to theMMSE,
EXIT 25 discriminated between groups, and presented good
psychometric properties, namely good internal consistency,
inter-rater reliability, and strong correlations with standard EF
measures, including the Trail Making Test B (TMT-B), the
Test of Sustained Attention, and the WCST (Ray et al., 1992;
Royall et al., 1992). Associations between higher EXIT 25 scores
and disruptive behaviors (Ray et al., 1992), functional decline
(Royall et al., 2004; Pereira et al., 2008), and probability of
dementia (Stokholm et al., 2006) were also found. Left anterior
frontal lobes lesions related to worse EXIT 25 performance in
studies with vascular and AD patients, even when controlling
for age, dementia type and severity (Royall et al., 2001). Further
studies also confirmed EXIT 25’s ability to detect executive
dysfunction in neurodegenerative (e.g., AD, FTD; Stokholm
et al., 2006; Azcurra, 2013) and non-degenerative (e.g., traumatic
brain injury; Larson et al., 2008) conditions. However, it failed
to differentiate between patients with probable AD with and
without major depression, vascular dementia without cortical
features, and schizophrenia (Royall et al., 1994). Another
limitation of EXIT 25 is its significant correlations with non-EF
measures such as the MMSE (Royall et al., 1992; Matioli et al.,
2008; Campbell et al., 2014), the California Verbal Learning Test
and the Finger Taping Test (Campbell et al., 2014). This could
indicate poor specificity (Dubois et al., 2000). Campbell et al.
(2014) argued that although poor scores on EXIT 25 indicate
cognitive deficits with an executive component, it is not a specific
measure of EF alone. There are validation studies for countries
like the United Kingdom (Mujic et al., 2014), Argentina (Azcurra,
2013), Brazil (Matioli et al., 2008), China (Chan et al., 2006), and
Israel (Sinoff et al., 2001), but normative data and cut-offs were
not provided. Shorter versions have been presented. The Quick
EXIT (Larson and Heinemann, 2010) incudes 14-items and
shows good internal consistency (Cronbach’s alpha = 0.88) and
moderate correlations with other measures of EF such as TMT
(Campbell et al., 2014). The EXIT 8 (Jahn et al., 2015) is an 8-item
version that shows good internal consistency (Cronbach’s alpha=
0.74), high correlation with the full EXIT 25, and good ability to
discriminate controls from patients (Area Under Curve—AUC
= 0.81 for Mild Cognitive Impairment, and AUC = 0.92 for
dementia). EXIT 8 remains a significant predictor of other EF
measures after controlling for MMSE scores, which suggests that
it might be a robust measure. Despite the good indicators, studies
considering other clinical populations are warranted.
To derive a more specific tool than EXIT 25, Dubois et al.
(2000) developed the FAB, which became the most widely used
screening tool for EF. It takes around 10min to administer,
and consists of six subtests that assess conceptualization, mental
flexibility, motor programming, sensitivity to interference,
inhibitory control, and environmental autonomy. Higher values
(minimum of 0 and maximum of 18) indicate better EF.
The FAB presented good inter-rater reliability and internal
consistency, strong positive correlations with the WCST,
and a good discriminative ability between controls and
patients with Parkinson’s disease, corticobasal degeneration,
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FTD, and progressive supranuclear palsy (Dubois et al., 2000).
Its psychometric properties were further inspected: strong
correlations were found with measures such as TMT, verbal
fluency (Lima et al., 2008; Rodrigues et al., 2009) and Stroop
Test (Rodrigues et al., 2009), as well as high inter-rater reliability
(Appollonio et al., 2005), and high accuracy in differentiating
controls from patients with FTD (Slachevsky et al., 2004; Lipton
et al., 2005), Parkinson’s disease (PD; Lima et al., 2008), AD
(Slachevsky et al., 2004; Guedj et al., 2008), Huntington’s disease
(Rodrigues et al., 2009), and amyotrophic lateral sclerosis (Barulli
et al., 2015). Associations were found between FAB performance
and regional cerebral glucose metabolism in dlPFC and middle
frontal gyri areas in AD patients (Oshima et al., 2012; Lee et al.,
2015), with dorsolateral prefrontal cortex and parietal lobe areas
in PD patients (Brugger et al., 2015), and with perfusion in the
dlPFC, medial premotor cortex and anterior cingulate cortex in
bvFTD patients (Guedj et al., 2008; for a review of FAB neural
correlates seeHurtado-Pomares et al., 2017). Different versions of
this tool and normative data are available, for example, in Iranian
(Asaadi et al., 2016), German (Benke et al., 2013), Brazilian
Portuguese (Beato et al., 2012), Korean (Kim et al., 2010),
European Portuguese (Lima et al., 2008), Turkish (Tunçay et al.,
2008), Japanese (Kugo et al., 2007), Italian (Iavarone et al., 2004;
Appollonio et al., 2005), and Chinese (Mok et al., 2004; Chong
et al., 2010). A cut-off of 12 distinguished between FTD and
AD patients with good sensitivity and specificity (Iavarone et al.,
2004; Slachevsky et al., 2004). For patients with Huntington’s
disease, a cut-off of 10/11 achieved the best sensitivity and
specificity (Rodrigues et al., 2009). In comparisons with EXIT
25, it was noticed that despite their similarities, FAB was briefer
and easier to administer in a memory clinic setting (Moorhouse
et al., 2009). Its contribution for differential diagnosis remains
non-consensual, however. FAB differentiated patients with AD
and vascular dementia (Oguro et al., 2006). Concerning byFTD
andADpatients, although bvFTD presented lower scores in some
studies (Iavarone et al., 2004; Slachevsky et al., 2004; Nakaaki
et al., 2007), in other studies differences were not significant
(Castiglioni et al., 2006; Gleichgerrcht et al., 2011). Additionally,
some of its subtests have been shown to have poor sensitivity
(e.g., Prehension Behaviour and Letter Fluency; Lima et al., 2008;
Moreira et al., 2014). Age (Iavarone et al., 2004; Appollonio
et al., 2005; Lima et al., 2008) and education (Iavarone et al.,
2004; Appollonio et al., 2005; Rodrigues et al., 2009) should
be considered when interpreting FAB scores, since they are
predictors of performance, with advanced age and less years of
education predicting lower scores. FAB correlates with MMSE
in many studies (e.g., Lima et al., 2008; Moorhouse et al., 2009;
Rodrigues et al., 2009), suggesting that, like EXIT 25, thismeasure
relates to other cognitive domains.
More recently, Torralva et al. (2009) developed the Institute
of Cognitive Neurology (INECO) Frontal Screening (IFS). The
IFS takes around 10min to administer, includes eight subtests
that cover three executive domains (response inhibition and
set shifting, abstraction, and working memory), and assess
processes such asmotor programming, sensitivity to interference,
inhibitory control, verbal inhibitory control, abstraction, and
working memory. Three subtests (Motor series, Conflicting
instructions, and Go-no-go) were taken from FAB, whereas
the remaining ones (Backward digit span; Months of the year
backward; Modified Corsi block, Proverb interpretation and
Modified Hayling test) were selected to optimize sensitivity. The
total score ranges from 0 to 30, with higher scores indicating
better performance. Psychometric properties were reported: good
internal consistency and concurrent validity, as shown by strong
correlations with standard measures of EF such as the WCST,
TMT-B (Torralva et al., 2009; Gleichgerrcht et al., 2011) and
Lexical and Semantic Fluency (Torralva et al., 2009; Ihnen et al.,
2013). Additionally, associations with functional measures have
been found, such as the Activities of Daily Living Scale (Ihnen
et al., 2013). The IFS discriminate between healthy controls and
patients with bvFTD (Torralva et al., 2009; Gleichgerrcht et al.,
2011; Fiorentino et al., 2013; Custodio et al., 2016), AD (Torralva
et al., 2009; Gleichgerrcht et al., 2011; Moreira et al., 2014;
Custodio et al., 2016), relapsing–remitting multiple sclerosis
(Bruno et al., 2015), bipolar disorder and ADHD (Baez et al.,
2014), as well as between clinical conditions, with bvFTD patients
scoring lower than those with major depression (Fiorentino et al.,
2013) and AD (Torralva et al., 2009; Custodio et al., 2016). Cut-
offs have been presented throughout the studies, with overall
values of sensitivity and specificity above 70%: 23.5 (Custodio
et al., 2016) and 25 (Torralva et al., 2009) for the detection of
dementia, and 17.5 (Custodio et al., 2016) and 19 (Torralva et al.,
2009) for the discrimination between bvFTD and AD patients. In
a sample with lower education, Moreira et al. (2014) showed that
an optimal cut-off of 17 discriminated between healthy controls
from AD patients. Only one study explored the neural correlates
of IFS, finding that total scores were associated with atrophy in
the amygdala, the hippocampus, the parahippocampal gyrus, the
fusiform gyrus, and the orbitofrontal cortex in bvFTD patients
(Baez et al., 2017). Comparisons between IFS and FAB were
undertaken, and these have shown that IFS is more sensitive and
specific in differentiating bvFTD from AD (Gleichgerrcht et al.,
2011; Custodio et al., 2016), and it also correlates more strongly
with standard executive tasks (e.g., TMT-B,WCST, Gleichgerrcht
et al., 2011). Nonetheless, the advantage of IFS over FAB remains
to be established: in a studywith ADpatients, they showed similar
diagnostic accuracy (0.88 and 0.87, respectively) and similar
correlations with other measures of EF (Moreira et al., 2014).
IFS scores also correlate with MMSE scores (Torralva et al., 2009;
Ihnen et al., 2013; Moreira et al., 2014) and are influenced by age
(Moreira et al., 2014) and education (Ihnen et al., 2013; Moreira
et al., 2014), reinforcing the need of normative data to take these
variables into account. To our knowledge, though, normative
data are only available for the Portuguese IFS (Moreira et al.,
2014).
Finally, Leslie et al. (2015) developed the FRONTIER
Executive Screen (FES), a tool that combines tasks believed to
differentiate bvFTD from AD, namely verbal fluency, inhibition,
and working memory. The scores range from 0 to 15, with
higher values indicating better performance. The FES showed
good discriminant accuracy between controls and patients, and
between AD and bvFTD groups (a cut-off of 7 reached good
sensitivity and specificity). Strong correlations with standard
EF measures were found (TMT-B, Digit Span Backward, and
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the Hayling Test). However, compared with the other screening
tools, FES covers less executive domains, and this could reduce
its sensitivity. Additionally, the highly specific FES goal—to
differentiate patients with bvFTD and AD—, along with the
absence of normative data, may limit its clinical usefulness.
Studies focused on the influence of sociodemographic variables
in FES performance and on its neural correlates remain to be
conducted as well.
DISCUSSION AND FUTURE DIRECTIONS
Deficits in EF are a symptom of several disorders and screening
tools are a promising method for their reliable and fast
assessment. We have discussed the four screening tools of EF
currently available. A common feature to the discussed tools
is the emphasis on metacognitive EF. Thus, for patients with
deficits in affective/social components (e.g., bvFTD; Rahman
et al., 1999; Eslinger et al., 2012), theymight providemore limited
information. The Social Cognition and Emotional Assessment
(SEA; Funkiewiez et al., 2012) andmini SEA (Bertoux et al., 2012)
could be an option in these cases, though they take longer than
30min to be completed.
Special attention has been given to the psychometric
properties of screening tools of EF, as these are critical to
determine their clinical utility (Cullen et al., 2007; Larner, 2013a).
All the discussed tools show good psychometric properties
according to the available guidelines (Malloy et al., 1997). Apart
from the FES, that still lacks this analysis, all of them show
good internal consistency and inter-rater reliability. The IFS and
FES show similar accuracy in detecting executive impairments in
bvFTD as compared to AD. In turn, FES seems to be more prone
to wrong classifications, as indicated by its lower specificity.
Correlations with standard executive measures were consistently
found. However, all the executive screening tools also presented
correlations with measures of global cognition like the MMSE.
This has been pointed out as a limitation, i.e., a sign of low
specificity. Nonetheless, considering the multifaceted nature of
EF, it is reasonable to expect that they influence performance in
global cognitivemeasures, as these include executive components
themselves. More studies will be needed to establish whether
screening tools of EF provide information that is useful over and
above that provided by global cognitive measures.
The availability of normative data is key for clinical practice:
conclusions about deficits are more reliable if performance
is compared against population data matched for age and
education. Unfortunately, insufficient attention has been given to
this. Only FAB and IFS presented normative studies, and only in
some of the countries where they have been validated. This limits
the utility of these tools and deserves more attention in future
work.
Another point that deserves more attention in future
research is the relative usefulness of executive screening
tools in the different stages of neurodegenerative diseases.
Progression generally occurs toward generalized deficits (Horton
and Wedding, 2008), and this makes the interpretation
(and diagnostic value) of domain-specific assessments more
challenging. Executive screening tools could be useful for
differential diagnosis in earlier stages of the disease (when
combined with other measures), while their contribution in
later stages could be more related to the description of the
neurocognitive phenotype, i.e., the pattern of relatively preserved
and impaired functions.
The relationship between screening tools and brain structure
and function remains poorly explored as well. This is crucial to
examine whether these tools recruit the same systems that have
been identified in experimental cognitive neuroscience research.
For EXIT 25 and FAB, there is some evidence of associations with
prefrontal structures. However, this remains poorly explored for
the IFS and unknown for the FES.
Apart from FES, which is briefer, the remaining executive
screening tools are relatively similar concerning structure, time
of application, covered domains, and psychometric properties.
More comparative research will be critical, across different
clinical groups, to establish in which conditions each of the
available tools is most useful. Larner (2013b), for example,
compared some screening measures of global cognition,
providing conclusions that are highly valuable for clinicians.
Some attempts to compare FAB, EXIT 25, and IFS in AD and
bvFTD patients have been made, but conclusive evidence is still
missing.
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